View in EDS

Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I-III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II study protocol.

Saved in:
Bibliographic Details
Title: Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I-III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II study protocol.
Authors: Justesen TF; Center for Surgical Science, Zealand University Hospital, Koge, Denmark toju@regionsjaelland.dk., Gögenur I; Center for Surgical Science, Zealand University Hospital, Koge, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Tarpgaard LS; Department of Oncology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Pfeiffer P; Department of Oncology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Qvortrup C; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.
Source: BMJ open [BMJ Open] 2023 Jun 22; Vol. 13 (6), pp. e073372. Date of Electronic Publication: 2023 Jun 22.
Publication Type: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37349100
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I-III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II study protocol.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Justesen+TF%22">Justesen TF</searchLink>; Center for Surgical Science, Zealand University Hospital, Koge, Denmark toju@regionsjaelland.dk.<br /><searchLink fieldCode="AU" term="%22Gögenur+I%22">Gögenur I</searchLink>; Center for Surgical Science, Zealand University Hospital, Koge, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Tarpgaard+LS%22">Tarpgaard LS</searchLink>; Department of Oncology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.<br /><searchLink fieldCode="AU" term="%22Pfeiffer+P%22">Pfeiffer P</searchLink>; Department of Oncology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.<br /><searchLink fieldCode="AU" term="%22Qvortrup+C%22">Qvortrup C</searchLink>; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101552874%22">BMJ open</searchLink> [BMJ Open] 2023 Jun 22; Vol. 13 (6), pp. e073372. <i>Date of Electronic Publication: </i>2023 Jun 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101552874 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-6055 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220446055%22">20446055 </searchLink><i>NLM ISO Abbreviation: </i>BMJ Open <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37349100
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/bmjopen-2023-073372
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e073372
    Titles:
      – TitleFull: Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I-III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II study protocol.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Justesen TF
      – PersonEntity:
          Name:
            NameFull: Gögenur I
      – PersonEntity:
          Name:
            NameFull: Tarpgaard LS
      – PersonEntity:
          Name:
            NameFull: Pfeiffer P
      – PersonEntity:
          Name:
            NameFull: Qvortrup C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 06
              Text: 2023 Jun 22
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2044-6055
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: BMJ open
              Type: main
ResultId 1